Posted from Patent Law Blog (Patently-O) 138 days ago
Patent Law : News
Merck v. Apotex (Fed. Cir. 2008) (non-precedential) Apotex filed an abbreviated new drug application (ANDA) to begin making a generic version of the osteoporosis drug FOSAMAX. The drug brought in over $3 billion in 2007. Merck sued for infringement and...
(original story)